Grand Pharmaceutical Group Investor Relations Material
Latest events
H1 2025
19 Aug, 2025
H2 2024
19 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Grand Pharmaceutical Group Limited
Access all reports
Grand Pharmaceutical Group Limited is a healthcare company engaged in the research, development, manufacturing, and distribution of pharmaceutical and medical products. The company specializes in prescription drugs, biopharmaceuticals, medical devices, and consumer healthcare products, serving therapeutic areas such as cardiovascular, respiratory, oncology, and ophthalmology. The company is headquartered in Wuhan, China, and its shares are listed on the Hong Kong Stock Exchange (HKEX).
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
512
Country
🇭🇰 Hong Kong